IGHV and Interphase Cytogenetics in a Patient With Chronic Lymphocytic Leukemia

JAMA Oncol. 2015 Aug;1(5):681-2. doi: 10.1001/jamaoncol.2015.1297.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adenine / analogs & derivatives
  • Aged
  • Antineoplastic Agents / therapeutic use
  • Biomarkers, Tumor / genetics*
  • Cytogenetic Analysis*
  • DNA Mutational Analysis
  • Female
  • Genes, Immunoglobulin Heavy Chain*
  • Genetic Predisposition to Disease
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
  • Leukemia, Lymphocytic, Chronic, B-Cell / genetics*
  • Leukemia, Lymphocytic, Chronic, B-Cell / immunology
  • Middle Aged
  • Mutation*
  • Phenotype
  • Piperidines
  • Predictive Value of Tests
  • Protein Kinase Inhibitors / therapeutic use
  • Pyrazoles / therapeutic use
  • Pyrimidines / therapeutic use
  • Risk Factors
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Piperidines
  • Protein Kinase Inhibitors
  • Pyrazoles
  • Pyrimidines
  • ibrutinib
  • Adenine